UK regulator authorises Pfizer-BioNTech shot for JN.1 COVID variant

(Reuters) – Britain’s health regulator said on Wednesday it has authorised Pfizer and BioNTech’s updated COVID-19 vaccine that targets the JN.1 subvariant of the coronavirus for use in infants, children and adults.

(Reporting by Unnamalai L in Bengaluru; Editing by Shounak Dasgupta)